Clinical Trial Update: Onvansertib + Paclitaxel In TNBC [Phase 1, Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 1/2 clinical trial evaluating the combination of onvansertib with paclitaxel in patients with triple-negative breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-negative Breast Cancer
• Inflammatory Breast Cancer
• Invasive Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Onvansertib (onvansertib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Antonio Giordano, MD | Conditions: Breast Cancer, Invasive Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING